JP2003245057A - Favorite food additive - Google Patents

Favorite food additive

Info

Publication number
JP2003245057A
JP2003245057A JP2002048281A JP2002048281A JP2003245057A JP 2003245057 A JP2003245057 A JP 2003245057A JP 2002048281 A JP2002048281 A JP 2002048281A JP 2002048281 A JP2002048281 A JP 2002048281A JP 2003245057 A JP2003245057 A JP 2003245057A
Authority
JP
Japan
Prior art keywords
extract
salasia
plant
salacia
action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002048281A
Other languages
Japanese (ja)
Inventor
Yoshito Hirai
義人 平井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAKAMOTO YAKUSOEN KK
Sakamoto Yakusoen KK
Original Assignee
SAKAMOTO YAKUSOEN KK
Sakamoto Yakusoen KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SAKAMOTO YAKUSOEN KK, Sakamoto Yakusoen KK filed Critical SAKAMOTO YAKUSOEN KK
Priority to JP2002048281A priority Critical patent/JP2003245057A/en
Publication of JP2003245057A publication Critical patent/JP2003245057A/en
Pending legal-status Critical Current

Links

Landscapes

  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Tea And Coffee (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a favorite food additive which enables the simultaneous intake of the crude medicine action-having ingredients of a Salasia plant (Salasia reticulata, Salasia oblonga, or Salasia prinoides) on the eating or drinking of a daily favorite food and can reasonably prevent diabetes and obesity due to the excessive intake of carbohydrates. <P>SOLUTION: This favorite food additive is obtained by formulating the extract of the Salasia plant into powdery or milky milk or its substitute. <P>COPYRIGHT: (C)2003,JPO

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、嗜好品であるコー
ヒーや紅茶などに添加される粉末状または乳状ミルクあ
るいはその代替品の改良に関し、詳細には、これらミル
ク等に、抗糖尿病作用や抗肥満作用、ダイエット作用な
どを有することが知られている生薬エキスを含有させ、
人体への糖類の吸収阻害作用を本来の風味を害すること
なく発現し得るように改善された嗜好品添加剤に関する
ものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to improvement of powdered or milky milk added to coffee and tea, which are favorite products, or a substitute thereof. Contains a crude drug extract known to have an obesity effect, a diet effect, etc.,
The present invention relates to a luxury food additive improved so that the absorption of saccharides into the human body can be exhibited without impairing the original flavor.

【0002】[0002]

【従来の技術】サラシア属の植物の中に抗糖尿病作用を
有する成分を含むものが存在することは周知である。こ
のことは、例えばスリランカ国の書物である「SINHALES
E MATERIA MEDICA」(JOHN ATTYGALLE著、LAKEHOUSE
BOOKSHOP 1917年発刊)にも記述されている通りであ
り、実際には、該書物が発刊されるかなり以前から現地
では生薬として活用されていたものと考えられる。
2. Description of the Related Art It is well known that some plants of the genus Salacia contain a component having an antidiabetic effect. This is, for example, a book in Sri Lanka called "SINHALES
E MATERIA MEDICA "(JOHN ATTYGALLE, LAKEHOUSE
BOOKSHOP published in 1917), it is believed that it was actually used as a crude drug in the field long before the publication of the book.

【0003】本発明者は、こうした伝承生薬の現代医学
的薬効やその有効成分、作用機能・毒性などの科学的解
明を期してかねてより研究を行っている。こうした研究
の一環として、サラシア属(サラシア レティキュラー
タ;Salasia reticulata、サラシア オブロンガ;Sal
asia oblonga、およびサラシア プリノイデス;Salas
ia prinoidesニシキギ科)の植物が、実際に糖尿病予
防作用や肥満抑制作用を有していること、そしてこうし
た作用は、該植物中に含まれる成分の一部が、糖分の分
解を調整し過剰なエネルギー源となるブドウ糖の血液中
への移行をコントロールする糖質分解酵素であるα−グ
ルコシダーゼに対して阻害作用を示すことによって発揮
されることを突き止め、更にはその有効成分化合物を特
定することに成功し、先に特許第303008号を取得してい
る。
The present inventor has been conducting research for some time in order to scientifically elucidate the medicinal efficacy of modern herbal medicines, their active ingredients, their function and toxicity. As part of this research, the genus Salacia (Salasia reticulata; Salasia oblonga; Sal
asia oblonga, and Salacia purinoides; Salas
ia prinoides plants (Euaceae) actually have a diabetes-preventing action and an obesity-suppressing action. To find out that it is exerted by showing an inhibitory effect on α-glucosidase, which is a glycolytic enzyme that controls the transfer of glucose as an energy source into blood, and further to identify its active ingredient compound. It succeeded and obtained the patent No. 303008 first.

【0004】そして上記サラシア属の植物は、インド、
スリランカ、タイ、ベトナム、中国南部地域などに豊富
に生育していることから、現在はそれらの野生種を採取
して生薬としての加工、研究が進められ、最近ではその
栽培技術についての研究も進められている。
The plants of the genus Salacia are Indian,
Since it is abundantly grown in Sri Lanka, Thailand, Vietnam, southern China, etc., currently, wild species of these are being collected and processed and researched as crude drugs.Recently, research on their cultivation techniques is also advanced. Has been.

【0005】他方、我国における食生活は、大和民族が
かつて経験したことのないほど豊かになっており、また
急激な技術革新と生活スタイルの変化は、車社会に代表
される如く人間の運動不足をますます助長する傾向が見
られる。そして我国では、こうした豊かな食生活と運動
不足が相俟って、今や国民病と呼ばれるほどに糖尿病疾
患者が増大してきており、国や地方自治体においても様
々の解決策が講じられているが、それほどの実効は上が
っていないのが実情である。
On the other hand, the eating habits in Japan have become richer than the Japanese people have ever experienced, and rapid technological innovation and changes in lifestyles have led to a lack of exercise by humans as represented by the car society. There is a tendency to promote more and more. In Japan, combined with such abundant eating habits and lack of exercise, the number of people with diabetes mellitus is now increasing to what is called the national illness, and various solutions are being taken by the national and local governments. The reality is that the effectiveness has not improved so much.

【0006】上記の様な状況に加えて、我国で糖尿病疾
患者が増大する原因の1つに、炭水化物主体の食生活が
挙げられる。即ち我国では主食の大半が炭水化物(米な
どの穀物)であり、該炭水化物は多糖類であるため、体
内での消化で多量の糖質が生成し体内に吸収されるから
である。
In addition to the above situation, one of the causes of increase in the number of people with diabetes mellitus in Japan is carbohydrate-based diet. That is, most of the staple foods in Japan are carbohydrates (grains such as rice), and since the carbohydrates are polysaccharides, a large amount of sugars are produced by digestion in the body and are absorbed in the body.

【0007】また、糖尿病疾患者が大幅に増大してきた
原因の他の1つに、例えばコーヒーや紅茶に代表される
嗜好飲料、或いはケーキやアイスクリーム等に代表され
る菓子類に甘味料として添加される砂糖からの糖分の過
剰摂取も軽視できない。
[0007] In addition, as another cause of the significant increase in the number of people with diabetes mellitus, it is added as a sweetener to favorite beverages typified by coffee and tea, or confectioneries typified by cakes and ice creams. The excess intake of sugar from the sugar used cannot be underestimated.

【0008】[0008]

【発明が解決しようとする課題】本発明は上記の様な事
情に着目してなされたものであって、その目的は、食生
活の主体となる炭水化物はもとより、現代では文化生活
に殆ど不可欠とも言える程に普及している嗜好品である
コーヒーや紅茶、更には菓子類などと共に砂糖として日
常的に摂取される糖質の体内への過剰吸収を抑え、糖尿
病やそれに起因する肥満を、日常的な嗜好品からの摂取
で効果的に予防し得るような嗜好品添加剤を提供するこ
とにある。
SUMMARY OF THE INVENTION The present invention has been made by paying attention to the above circumstances, and its purpose is not only carbohydrate, which is the main body of eating habits, but also that it is almost indispensable for cultural life in modern times. It is possible to prevent diabetes and obesity caused by it from being absorbed daily by suppressing excessive absorption into the body of sugars that are ingested daily as sugar along with coffee and tea, which are popular items that can be said, and confectioneries. Another object of the present invention is to provide an additive for luxury products that can be effectively prevented by ingestion from various luxury products.

【0009】[0009]

【課題を解決するための手段】上記課題を解決すること
のできた本発明に係る嗜好品用添加剤とは、サラシア属
(サラシア レティキュラータ;Salasia reticulat
a、サラシア オブロンガ;Salasia oblonga、および
サラシア プリノイデス;Salasia prinoidesニシキギ
科)の植物の抽出物を、粉末状または乳状のミルク若し
くはその代替品に配合してなるところに要旨が存在す
る。
[Means for Solving the Problems] The additive for luxury goods according to the present invention, which has been able to solve the above problems, is a genus Salacia (Salasia reticulat).
a, Salacia oblonga; Salasia oblonga, and Salacia prinoides; Eucalyptus family) plant extract is mixed with powdered or milky milk or its substitute.

【0010】本発明においては、上記植物の抽出物を、
上記粉末状または乳状のミルク若しくはその代替品に、
好ましくは乾燥基準で0.05〜5質量%含有させてお
き、これを、嗜好飲料として嗜まれるコーヒーや紅茶に
添加し、或いは食後のデザートとして食されるケーキな
どに用いる生クリームやホイップなどに添加しておけ
ば、これらを食事中もしくは食後に飲食することで、α
−グルコシダーゼの糖質分解酵素としての作用を阻害す
る上記抽出物を自然に摂取することができ、その作用を
有効に活かすことができる。
In the present invention, the above plant extract is
In the powdered or milky milk or its substitute,
Preferably, it is contained in an amount of 0.05 to 5% by mass on a dry basis, and is added to coffee or tea that is used as a favorite beverage, or in fresh cream or whipped cake that is used as a dessert after eating. If added, by eating or drinking these during or after meals, α
-The above-mentioned extract which inhibits the action of glucosidase as a glycolytic enzyme can be naturally taken, and the action can be effectively utilized.

【0011】従って本発明の好ましい使用形態として
は、嗜好品として日常的に嗜まれるコーヒーや紅茶など
の嗜好飲料などに添加する粉末ミルクや練乳、或いは、
ケーキなどの製造に用いる生クリームやホイップなどに
添加して使用する形態が挙げられる。
Therefore, as a preferred use form of the present invention, powdered milk or condensed milk to be added to favorite beverages such as coffee and tea that are commonly used as a favorite product, or condensed milk, or
Examples include a form in which the cream is added to fresh cream or whipped to be used for producing cakes and the like.

【0012】[0012]

【発明の実施の形態】本発明者らは前述したような課題
の下で、サラシア属植物の含有成分が有しているα−グ
ルコシダーゼに対する活性阻害作用、およびそれによる
糖尿病予防作用や肥満抑制作用などを、普通の食生活の
中で義務感や強制感などを抱くことなく極自然に効率よ
く発揮させるべく、様々の角度から検討を進めてきた。
Under the above-mentioned problems, the inventors of the present invention have an activity inhibiting action on α-glucosidase possessed by a component contained in a plant of the genus Salacia, and a diabetes preventive action and an obesity inhibiting action by the action. We have been studying from a variety of angles in order to efficiently and effectively demonstrate such things in a normal diet without feeling a sense of duty or compulsion.

【0013】その結果、前述の如く、生薬活性を有する
前記植物の抽出エキスを、粉末状または乳状のミルク若
しくはその代替品に適量配合しておき、これを、日常的
に嗜まれるコーヒーや紅茶などに添加して服用すれば、
前記生薬エキスを極自然に摂取できるとの発想を得、こ
うした発想を元に上記本発明に想到した。
As a result, as described above, powdered or milky milk or a substitute thereof is mixed with an appropriate amount of the extract of the plant having a herbal medicine activity, and this is used for daily use such as coffee and tea. If added to and taken
Based on the idea that the herbal medicine extract can be taken very naturally, the present invention has been made based on such an idea.

【0014】本発明に係る添加剤の有効成分となる植物
の抽出物は、前述した通り、サラシア属(サラシア レ
ティキュラータ;Salasia reticulata、サラシア オ
ブロンガ;Salasia oblonga、およびサラシア プリノ
イデス;Salasia prinoidesニシキギ科)植物から抽出
されたものであって、その抽出物(以下、抽出エキスと
いうことがある)が糖尿病抑制作用や肥満抑制作用を有
し、更にはダイエット増進作用を有していることは公知
である。
As described above, the plant extract which is the active ingredient of the additive according to the present invention is derived from a plant of the genus Salacia (Salasia reticulata; Salasia oblonga; Salasia oblonga and Salasia prinoides; It is known that the extract (hereinafter sometimes referred to as an extract), which has been extracted, has a diabetes suppressing action and an obesity suppressing action, and further has a diet promoting action.

【0015】本発明は、基本的にはこうした抽出エキス
の作用を、薬剤感覚を持つことなく日常生活の中で極自
然に摂取できるようにしたもので、抽出源となるサラシ
ア属の植物の種類や該植物からの有価成分の抽出法など
は、本発明者らが先に開示している方法、例えば前記特
許第3030008号(特開平11−29472号公
報)や特開平11−116496号公報などに開示した
方法が実質的にそのまま適用することができ、或いは必
要により適当に変更を加えて実施できる。
The present invention basically enables the action of such an extract to be ingested extremely naturally in daily life without any drug sensation. The method of extracting valuable components from the plant or the plant is a method previously disclosed by the present inventors, for example, the above-mentioned Japanese Patent No. 3030008 (Japanese Patent Laid-Open No. 11-29472) and Japanese Patent Laid-Open No. 11-116496. The method disclosed in 1 above can be applied substantially as it is, or can be implemented with appropriate modifications if necessary.

【0016】ところで、上記生薬エキスを服用し、或い
は該生薬源である植物の乾燥品を健康茶として煎じて飲
用することにより生薬作用を得ることは、上記公報など
に限らず従来から行われている。
[0016] By the way, obtaining a crude drug action by taking the above crude drug extract or decocting and drinking a dried product of a plant which is the source of the crude drug as health tea is not limited to the above publications and the like. There is.

【0017】しかしそれらの生薬成分の摂取形態は、薬
剤としての摂取感覚を出ないため、少なからず服用者に
薬剤摂取の強制感や義務感を与え、ともすれば定期的な
服用を懈怠したり失念することが多い。そのため、定期
的且つ長期的は継続服用によってその作用がより効果的
に発揮される生薬については、日常的な生活習慣の中で
自然に且つ長期的に継続して服用可能にすることが望ま
れる。
However, since the mode of ingestion of these crude drug components does not give the feeling of ingestion as a drug, it gives the user a feeling of compulsion and obligation to take the drug, and in some cases neglects to take them regularly. I often forget. Therefore, it is desirable to allow natural and long-term continuous use of crude drugs whose effects are more effectively exerted by regular and long-term continuous administration in daily life habits. .

【0018】本発明は、こうした要望に沿うべく、前記
生薬成分をミルクなどに混入し、コーヒーや紅茶等と共
に嗜好感覚で摂取可能にするもので、本件出願人の知る
限りこうした服用形態を採用するといった発想はこれま
で全く存在せず、勿論その様な形態での摂取を可能にし
た商品は提供されていない。即ち本発明では、嗜好感覚
で日常的に摂取可能にするための手段として、言わば盲
点としてこれまで何人も試みたことのない「嗜好品用添
加剤中に生薬成分エキスを含有させる」点に最大の特徴
を有するものである。
In order to meet such demands, the present invention mixes the above-mentioned herbal medicine components into milk or the like, and allows ingestion with coffee or tea with a taste sensation. As far as the applicant of the present invention knows, such a dosage form is adopted. Up to now, such an idea has not existed at all, and, of course, products that enable ingestion in such a form have not been offered. That is, in the present invention, as a means for allowing daily ingestion with a taste sensation, the maximum point is "to include a crude drug component extract in an additive for a luxury item" that no one has tried so far as a blind spot. It has the characteristics of

【0019】よって、本発明で使用する前記生薬成分の
源となる植物の種類や有価成分の抽出法等には一切制限
がなく、また該有価成分が添加される食品についても格
別の制限は存在しない。
Therefore, there is no restriction on the kind of plant used as the source of the herbal medicine ingredient used in the present invention, the extraction method of the valuable ingredient, and the food to which the valuable ingredient is added has particular limitation. do not do.

【0020】但し本発明では、サラシア属の前記植物が
有している特に糖尿病予防や肥満防止といった作用をよ
り効果的に発揮させるため、食事中もしくは食後に飲用
されることの多いコーヒーや紅茶への一般的な添加剤で
あるミルクやクリーム(粉末状や乳状を含む)やその代
替品に添加することを定めている。なおクリームやその
代替品であるホイップなどはケーキやアイスクリームな
どの冷菓にも広く使用されており、ケーキなどは食後の
デザートとして飲食されることも多いので、本発明で
は、該クリームやホイップなどに前記生薬エキスを混入
させる態様も包含される。
However, in the present invention, in order to more effectively exert the action of the above-mentioned plant of the genus Salacia particularly in preventing diabetes and obesity, coffee or tea often consumed during or after meals is added. It is stipulated to be added to milk and cream (including powder and milk) which are general additives of, and their substitutes. It should be noted that cream and its substitutes, such as whipped, are widely used for frozen desserts such as cakes and ice cream, and cakes are often eaten and desserts after meals. A mode in which the crude drug extract is mixed with the above is also included.

【0021】ミルクなどへの前記生薬エキスの添加量は
特に制限されないが、その生薬としての作用をより有効
に発揮させるための用量は、後記実施例でも明らかにす
る如くヒト1回当たり25〜50mg程度が適当と思わ
れ、こうした用量を確保するには、ミルク等に乾燥基準
で該生薬エキスを0.05〜5質量%、より好ましくは
0.5〜1質量%程度含有させておくことが薦められ
る。但し、その添加量は、服用者の肥満の程度に応じて
適宜増減することが可能であり、その要求度合いに応じ
て含有量をランク付けしておくことも有効である。
The amount of the crude drug extract added to milk or the like is not particularly limited, but the dose for more effectively exhibiting its action as a crude drug is 25 to 50 mg per human dose, as will be made clear in the Examples below. The amount seems to be appropriate, and in order to secure such a dose, milk or the like should contain 0.05 to 5% by mass, more preferably 0.5 to 1% by mass of the crude drug extract on a dry basis. Recommended However, the added amount can be appropriately increased or decreased according to the degree of obesity of the recipient, and it is also effective to rank the content according to the required degree.

【0022】いずれにしても、本発明に係る生薬エキス
の添加された嗜好品用添加剤は、食事中もしくは食後な
どに嗜まれるコーヒーや紅茶などの嗜好飲料に添加して
服用され、或いはケーキ等のクリーム中に含まれた状態
で服用されるので、これら嗜好品中に含まれる糖分はも
とより、食事の主食として摂取されるご飯やパンなどの
炭水化物に由来する糖質の分解や過剰エネルギー源とし
てのブドウ糖の血中移行を増進するα−グルコシダーゼ
の作用が阻害され、糖尿病等の予防に有効に作用する
他、肥満を防止し、或いは更に糖尿病予備軍とも言われ
る肥満者のダイエット促進に有効に作用する。
In any case, the additive for luxury products to which the herbal medicine extract of the present invention is added is taken by adding it to a favorite beverage such as coffee or tea which is used during meals or after meals, or cakes or the like. Since it is taken in the state of being contained in the cream, it is used as a source of excess energy as well as the sugar contained in these luxury products, as well as the decomposition of carbohydrates derived from carbohydrates such as rice and bread that are ingested as staple foods. The action of α-glucosidase that promotes glucose transfer into blood is inhibited, which effectively acts to prevent diabetes and the like, and also prevents obesity, or effectively promotes a diet for obese persons, who is also called a diabetic reserve army. To work.

【0023】[0023]

【実施例】以下、実験例を挙げて本発明をより具体的に
説明するが、本発明はもとより下記実験例によって制限
を受けるものではなく、前・後記の趣旨に適合し得る範
囲で適当に変更して実施することも可能であり、それら
は何れも本発明の技術的範囲に包含される。
EXAMPLES The present invention will be described in more detail with reference to the following experimental examples. However, the present invention is not limited by the following experimental examples, and may be appropriately applied within the scope of the above and the following points. Modifications can be made, and all of them are included in the technical scope of the present invention.

【0024】実施例 サラシア属のサラシア レティキュラータ(スリランカ
およびインド産)、サラシア オブロンガ(インド
産)、サラシア プリノイデス(タイ産、ベトナム産、
中国広東産)を採取し、現地で十分に乾燥して市販され
ているもの購入し、各々1kgを粗切りし原料として用
いた。
Example Salacia reticulata of the genus Salacia (from Sri Lanka and India), Salacia oblonga (from India), Salacia purinoides (from Thailand and Vietnam,
(Produced in Guangdong, China) was collected, sufficiently dried locally, and purchased commercially, and 1 kg of each was roughly cut and used as a raw material.

【0025】抽出法は、各々の粗切物を20リットルの
水に加えて90〜95℃で3時間抽出してから、濾液を
45℃以下で減圧濃縮し、溶媒を完全に留去した。得ら
れた濃縮物のエキス収率を下記表1に示す。また、該濃
縮物をデシケータ中で1昼夜保存してから、下記の方法
でα−グルコシダーゼ阻害活性を調べ、結果を表1に併
記した。
In the extraction method, each crude cut product was added to 20 liters of water and extracted at 90 to 95 ° C. for 3 hours, and then the filtrate was concentrated under reduced pressure at 45 ° C. or lower to completely remove the solvent. The extract yield of the obtained concentrate is shown in Table 1 below. In addition, the concentrate was stored in a desiccator for one day and night, and then the α-glucosidase inhibitory activity was examined by the following method, and the results are also shown in Table 1.

【0026】[α−グルコシダーゼ阻害活性の測定法]
蔗糖37mMを正確に秤取し、上記濃縮物を夫々20m
g加えて更に全量が1000mLとなる様に水を加えて
溶解させ、試料溶液とする。一方、α−グリコシダーゼ
(和光純薬工業製の生化学用α−グルコシダーゼ、起
源;Saccharomyses sp、活性;120units/mg)10mg
を精秤して水100mLに溶解し、酵素液を調製する。
[Method for measuring α-glucosidase inhibitory activity]
Accurately weigh 37 mM of sucrose and add 20 m of each of the above concentrates.
g and further add water so that the total amount becomes 1000 mL, and dissolve to make a sample solution. On the other hand, α-glycosidase (α-glucosidase for biochemistry manufactured by Wako Pure Chemical Industries, origin: Saccharomyses sp, activity; 120 units / mg) 10 mg
Is precisely weighed and dissolved in 100 mL of water to prepare an enzyme solution.

【0027】上記で得た試料溶液と酵素液を夫々0.7
mM精秤してよく混合し、37℃で30分間インキュベ
ートした後、水0.8mLを加えてから90〜100℃
で2分間加熱し、得られた各反応液について、グルコー
ス測定キット(和光純薬工業社製の体外診断用医薬品
「グルコースCII−テストワコー」)を用いてIC50値を
測定する。
The sample solution and the enzyme solution obtained above were each added to 0.7
mM Weigh precisely and mix well, incubate at 37 ° C for 30 minutes, then add 0.8 mL of water, then 90-100 ° C
The mixture is heated for 2 minutes, and the IC 50 value of each of the obtained reaction solutions is measured using a glucose measurement kit (in-vitro diagnostic drug “Glucose CII-Test Wako” manufactured by Wako Pure Chemical Industries, Ltd.).

【0028】[0028]

【表1】 [Table 1]

【0029】表1からも明らかな様に、サラシア属の前
記植物から5.6〜8.0質量%の収率で抽出されるエ
キスのα−グルコシダーゼ阻害活性は、20.1〜5
0.3μg/mlの範囲に収まることを確認できる。
As is clear from Table 1, the α-glucosidase inhibitory activity of the extract extracted from the plant of the genus Salacia in a yield of 5.6 to 8.0% by mass is 20.1 to 5%.
It can be confirmed that it falls within the range of 0.3 μg / ml.

【0030】次に、上記で得た各エキスを使用し、下記
の動物実験によって糖分摂取による血糖値上昇に対する
抑制作用を調べた。
Next, using each of the extracts obtained above, the inhibitory effect on the increase in blood glucose level due to sugar intake was examined by the following animal experiment.

【0031】即ち、20〜24時間絶食後の雄性dd-y系
マウス(体重28〜30g)に、上記で得た各エキスを
5%のアラビアゴム液に懸濁させてマウスに50mg/kg
経口投与し、更に30分後に蔗糖1g/kgを経口投与す
る。それから更に30分経過後に、各マウスから採血し
て血糖値を求めることにより、血糖上昇の阻害作用を定
量的に評価した。結果を表2に示す。
That is, each of the above-obtained extracts was suspended in a 5% gum arabic solution in a male dd-y mouse (body weight: 28 to 30 g) after fasting for 20 to 24 hours, and 50 mg / kg to the mouse.
Oral administration is performed, and 30 minutes later, 1 g / kg of sucrose is orally administered. After a further 30 minutes, blood was collected from each mouse to obtain a blood glucose level, thereby quantitatively evaluating the inhibitory effect on the blood glucose increase. The results are shown in Table 2.

【0032】[0032]

【表2】 [Table 2]

【0033】表2からも明らかな様に、サラシア属の前
記植物から抽出されたエキスは、何れも蔗糖摂取による
血糖値の上昇を抑える作用を有しており、即ち、α−グ
ルコシダーゼの糖質分解酵素としての作用を阻害するこ
とが分かる。特に、抽出エキスのIC50値が35μg/mlレ
ベル以上であるものは、蔗糖負荷群の対照群に対して6
0%以上の阻害率を示している。
As is clear from Table 2, each of the extracts extracted from the plants of the genus Salacia has an action of suppressing an increase in blood glucose level due to ingestion of sucrose, that is, a sugar of α-glucosidase. It can be seen that it inhibits the action as a degrading enzyme. In particular, the extract having an IC 50 value of 35 μg / ml or higher was 6% compared to the control group in the sucrose-loaded group.
The inhibition rate is 0% or more.

【0034】この結果から、サラシア属の前記植物から
の抽出エキスは、体内での糖質の分解による血糖値の上
昇を明らかに抑制する機能を有しており、糖尿病予防、
或いは糖質の過剰摂取による肥満の抑制に有効に作用し
得ると判断される。
From these results, the extract from the plant of the genus Salacia has the function of obviously suppressing the increase in blood glucose level due to the decomposition of sugars in the body, and is effective in preventing diabetes.
Alternatively, it is considered that it can effectively act on suppression of obesity due to excessive intake of sugar.

【0035】次に、上記で血糖値の上昇抑制効果を有す
ることが確認された「サラシア レティキュラータ」の
根部から抽出したエキスを使用し、その用量と上記阻害
活性の関係を調べた。実験は、用量を25mg/kg、50m
g/kg、75mg/kg、100mg/kgに変えた以外は前記と同
様にして行った。
Next, using the extract extracted from the root of "Salacia reticulata", which was confirmed to have the effect of suppressing the elevation of blood glucose level, the relationship between the dose and the inhibitory activity was examined. The experiment was 25 mg / kg, 50 m
The procedure was the same as that described above except that g / kg, 75 mg / kg and 100 mg / kg were used.

【0036】結果は表3に示す通りであり、「サラシア
レティキュラータ」の根部から抽出したエキスを50
mg/kg程度以上経口投与すると、蔗糖摂取による血糖値
の上昇をほぼ90%以上抑えることができ、75mg/kg
程度以上経口投与すると、ほぼ100%抑制されること
が分かる。
The results are shown in Table 3, and the extract extracted from the root of "Salacia reticulata" was added to 50
Oral administration of more than about mg / kg can suppress the increase in blood glucose level due to ingestion of sucrose by about 90% or more.
It can be seen that almost 100% inhibition is achieved by oral administration over a certain level.

【0037】[0037]

【表3】 [Table 3]

【0038】次に、前記「サラシア レティクラータ
(根部)」から抽出した乾燥エキス粉末を、その含有率
が10質量%となる様に液状ミルクに添加し、乳鉢で十
分に混合分散することにより、エキス含有ミルクを製造
した。そして、その0.25ml/kg(サラシア レティクラ
ータエキスとして5mg/kg含有)およびその2倍の0.5ml
/kg(サラシア レティクラータエキスとして10mg/kg
含有)を、前記と同様にしてマウスに経口投与し、血糖
値抑制作用を調べたところ、何れの場合も血糖値の上昇
阻害率で90%以上が得られた。
Next, the dry extract powder extracted from the above-mentioned "Salacia reticulata (root)" was added to liquid milk so that the content ratio was 10% by mass, and sufficiently mixed and dispersed in a mortar to obtain an extract. A milk containing was produced. And 0.25 ml / kg (containing 5 mg / kg as Salacia reticulata extract) and 0.5 ml twice that
/ kg (10 mg / kg as Salacia reticulata extract
Was orally administered to mice in the same manner as described above, and the inhibitory effect on blood glucose level was examined. In all cases, 90% or more was obtained as the inhibition rate of blood glucose elevation.

【0039】即ち上記乾燥エキスは、ミルクに添加して
服用した場合でも、α−グルコシダーゼの酵素活性阻害
作用には全く悪影響を及ぼすことがない。なお投与量は
体重に対する用量で定めるのが通例であり、ヒトの平均
体重は60kgであるから、ヒトへの投与量はマウスの
場合の約60倍に増大する必要があると思われる。しか
し通常の新薬開発試験の場合、実験動物に対して100mg/
kg程度で有効であれば、ヒトに対する用量は1回100mg
程度が好適とされており、よって、血糖値抑制のための
用量が25〜50mg/kgである上記抽出エキスでは、ヒ
トに対し1回25〜50mg程度の用量で、十分な血糖
値上昇抑制効果が発揮されるものと思われる。
That is, the above-mentioned dried extract has no adverse effect on the enzyme activity-inhibiting action of α-glucosidase even when added to milk and taken. The dose is usually determined by the dose based on the body weight, and since the average human body weight is 60 kg, it seems that the dose to human needs to be increased by about 60 times that in the case of mouse. However, in the case of usual new drug development tests, 100 mg /
If about kg is effective, the dose for humans is 100 mg once.
Therefore, the above extract having a dose of 25 to 50 mg / kg for suppressing the blood glucose level has a sufficient blood glucose level suppressing effect on humans at a dose of about 25 to 50 mg once. Is expected to be demonstrated.

【0040】また、上記実験で採用した程度のミルクに
対する抽出エキスの添加量であれば、コーヒーや紅茶の
風味や外観に悪影響を及ぼすこともないことを確認して
いる。
Further, it has been confirmed that the amount of the extracted extract added to milk to the extent adopted in the above experiment does not adversely affect the flavor and appearance of coffee or tea.

【0041】[0041]

【発明の効果】本発明は以上のように構成されており、
糖尿病予防作用や肥満防止作用を有することが確認され
ている前記サラシア属植物の抽出エキスを嗜好品用添加
剤中に含有させたものであるから、嗜好品と共に通常の
食生活の中で該有効成分を日常的、定期的且つ長期的に
無理なく継続して極自然に服用することができ、生薬成
分の作用を最大限有効に活かすことができる。
The present invention is configured as described above,
Since the extract extract of the Salacia plant which has been confirmed to have a diabetes preventive action and an obesity preventive action is contained in the additive for a luxury item, the effect in a normal diet along with the luxury item is effective. It is possible to take the ingredients as naturally as possible on a daily, regular, and long-term basis without difficulty and to take full advantage of the action of the herbal medicine ingredients.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 35/78 A61K 35/78 C A61P 3/04 A61P 3/04 3/10 3/10 ─────────────────────────────────────────────────── ─── Continued Front Page (51) Int.Cl. 7 Identification Code FI Theme Coat (Reference) A61K 35/78 A61K 35/78 C A61P 3/04 A61P 3/04 3/10 3/10

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 サラシア属(サラシア レティキュラー
タ;Salasia reticulata、サラシア オブロンガ;Sal
asia oblonga、およびサラシア プリノイデス;Salas
ia prinoidesニシキギ科)植物の抽出物を、粉末状ま
たは乳状のミルク若しくはその代替品に配合してなるこ
とを特徴とする嗜好品用添加剤。
1. A genus of Salacia (Salasia reticulata; Salicia oblonga; Sal
asia oblonga, and Salacia purinoides; Salas
ia prinoides (Euaceae) plant extract is mixed with powdered or milky milk or its substitute, which is an additive for luxury items.
【請求項2】 前記植物の抽出物を、前記粉末状または
乳状のミルク若しくはその代替品に、乾燥基準で0.0
5〜5質量%含有させたものである請求項1に記載の添
加剤。
2. The extract of the plant is added to the powdered or milky milk or its substitute on a dry basis of 0.0
The additive according to claim 1, which is contained in an amount of 5 to 5% by mass.
【請求項3】 前記嗜好品が、コーヒー、紅茶などの嗜
好飲料である請求項1または2に記載の添加剤。
3. The additive according to claim 1, wherein the favorite product is a favorite beverage such as coffee or tea.
JP2002048281A 2002-02-25 2002-02-25 Favorite food additive Pending JP2003245057A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002048281A JP2003245057A (en) 2002-02-25 2002-02-25 Favorite food additive

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002048281A JP2003245057A (en) 2002-02-25 2002-02-25 Favorite food additive

Publications (1)

Publication Number Publication Date
JP2003245057A true JP2003245057A (en) 2003-09-02

Family

ID=28661123

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002048281A Pending JP2003245057A (en) 2002-02-25 2002-02-25 Favorite food additive

Country Status (1)

Country Link
JP (1) JP2003245057A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004323420A (en) * 2003-04-24 2004-11-18 Morishita Jintan Kk NEW SUBSTANCE HAVING alpha-GLUCOSIDASE INHIBITORY ACTIVITY AND FOOD CONTAINING THE SAME
JP2006238811A (en) * 2005-03-04 2006-09-14 Amimoto Giken Kk Brown rice-containing soybean curd and method for producing the same
WO2009031690A2 (en) 2007-09-06 2009-03-12 Fujifilm Corporation Foodstuff comprising an extract of a plant of the genus salacia and flavonoid
JP2014529596A (en) * 2011-08-16 2014-11-13 アボット・ラボラトリーズAbbott Laboratories How to convert meals

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004323420A (en) * 2003-04-24 2004-11-18 Morishita Jintan Kk NEW SUBSTANCE HAVING alpha-GLUCOSIDASE INHIBITORY ACTIVITY AND FOOD CONTAINING THE SAME
JP4516282B2 (en) * 2003-04-24 2010-08-04 森下仁丹株式会社 Novel substance having α-glucosidase inhibitory activity and food containing the same
JP2006238811A (en) * 2005-03-04 2006-09-14 Amimoto Giken Kk Brown rice-containing soybean curd and method for producing the same
WO2009031690A2 (en) 2007-09-06 2009-03-12 Fujifilm Corporation Foodstuff comprising an extract of a plant of the genus salacia and flavonoid
WO2009031690A3 (en) * 2007-09-06 2009-05-22 Fujifilm Corp Foodstuff comprising an extract of a plant of the genus salacia and flavonoid
US8226991B2 (en) 2007-09-06 2012-07-24 Fujifilm Corporation Foodstuff comprising an extract of a plant of the genus Salacia and flavonoid
JP2014529596A (en) * 2011-08-16 2014-11-13 アボット・ラボラトリーズAbbott Laboratories How to convert meals

Similar Documents

Publication Publication Date Title
JP2005213227A (en) Use of blood sugar increase suppressing effect of d-psicose
JP2007077139A (en) Composition derived from citrus sudachi hort, pharmaceutical composition, health food and beverage and supplement containing the composition
TW200939975A (en) Dietary compositions for promoting weight loss
JP3302346B2 (en) Food composition
JPH10265397A (en) Agent for preventing obesity
JP5064652B2 (en) Diabetes prevention and treatment composition and health food containing active ingredients thereof
JP2002051735A (en) Food product composition
WO2008018139A1 (en) Antiobesity composition containing component originating in the bark of tree belonging to the genus acacia
JP2013075874A (en) Blood sugar metabolism improver
JP2003245057A (en) Favorite food additive
KR101952643B1 (en) Preparation method of grain noodle
JP2006104181A (en) Glucide-splitting enzyme-inhibiting material derived from fagaceae plant and application thereof
JP2001299273A (en) Health food and health drink
JP2000139406A (en) Antiallergic agent and anti-itching agent
JP4043645B2 (en) Yacon and mulberry leaves
WO2005056034A1 (en) Alga extract and lipase inhibitor containing the same
JP2000103741A (en) Lipase inhibitor
AU2022202545A1 (en) Oral hypoglycemic agents as food additives and supplements
JP2003189818A (en) Functional food containing powdery sea-squirt
JP2000166499A (en) Health food with blended hericium erinaceum
JP2003245095A (en) Method for evaluation of herb medicine activity of plant of genus salasia
KR102478971B1 (en) Composition for bowel movement promotion or diet
CN113712982B (en) Composition for preventing or treating non-alcoholic fatty liver disease and obesity, and preparation method and application thereof
WO2004019962A1 (en) Hair growth stimulants for oral use
JP2004000164A (en) alpha-GLUCOSIDASE INHIBITOR AND COMPOSITION

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040727

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050208

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20060529

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20061114

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070306